Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Celiac disease, inflammation and oxidative damage: a nutrigenetic approach.

Ferretti G, Bacchetti T, Masciangelo S, Saturni L.

Nutrients. 2012 Apr;4(4):243-57. doi: 10.3390/nu4040243. Epub 2012 Mar 27. Review.

2.

Proteomic analysis in allergy and intolerance to wheat products.

Mamone G, Picariello G, Addeo F, Ferranti P.

Expert Rev Proteomics. 2011 Feb;8(1):95-115. doi: 10.1586/epr.10.98. Review.

PMID:
21329430
3.

Variable activation of immune response by quinoa (Chenopodium quinoa Willd.) prolamins in celiac disease.

Zevallos VF, Ellis HJ, Suligoj T, Herencia LI, Ciclitira PJ.

Am J Clin Nutr. 2012 Aug;96(2):337-44. doi: 10.3945/ajcn.111.030684. Epub 2012 Jul 3.

4.

Wheat starch, gliadin, and the gluten-free diet.

Thompson T.

J Am Diet Assoc. 2001 Dec;101(12):1456-9.

PMID:
11762742
5.

In vitro proliferation of lymphocytes from celiac children and their first-degree relatives in response to wheat gliadin-derived peptides.

Auricchio S, Buffolano W, Ciccimarra F, De Vincenzi M, Silano V, Zapponi G.

J Pediatr Gastroenterol Nutr. 1982;1(4):515-24.

PMID:
7186066
6.

Targeting of prolamins by RNAi in bread wheat: effectiveness of seven silencing-fragment combinations for obtaining lines devoid of coeliac disease epitopes from highly immunogenic gliadins.

Barro F, Iehisa JC, Giménez MJ, García-Molina MD, Ozuna CV, Comino I, Sousa C, Gil-Humanes J.

Plant Biotechnol J. 2016 Mar;14(3):986-96. doi: 10.1111/pbi.12455. Epub 2015 Aug 24.

7.

Maize prolamins could induce a gluten-like cellular immune response in some celiac disease patients.

Ortiz-Sánchez JP, Cabrera-Chávez F, de la Barca AM.

Nutrients. 2013 Oct 21;5(10):4174-83. doi: 10.3390/nu5104174. Review.

8.

Two prolamin peptides from durum wheat preclude celiac disease-specific T cell activation by gluten proteins.

De Vincenzi M, Vincentini O, Di Nardo G, Boirivant M, Gazza L, Pogna N.

Eur J Nutr. 2010 Jun;49(4):251-5. doi: 10.1007/s00394-009-0080-4. Epub 2009 Nov 6.

PMID:
19894071
9.

Celiac disease: risk assessment, diagnosis, and monitoring.

Setty M, Hormaza L, Guandalini S.

Mol Diagn Ther. 2008;12(5):289-98. Review.

PMID:
18803427
10.

Testing safety of germinated rye sourdough in a celiac disease model based on the adoptive transfer of prolamin-primed memory T cells into lymphopenic mice.

Freitag TL, Loponen J, Messing M, Zevallos V, Andersson LC, Sontag-Strohm T, Saavalainen P, Schuppan D, Salovaara H, Meri S.

Am J Physiol Gastrointest Liver Physiol. 2014 Mar;306(6):G526-34. doi: 10.1152/ajpgi.00136.2013. Epub 2014 Jan 23.

11.

Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.

Shan L, Qiao SW, Arentz-Hansen H, Molberg Ø, Gray GM, Sollid LM, Khosla C.

J Proteome Res. 2005 Sep-Oct;4(5):1732-41.

12.
13.

Nutrigenetics and nutrigenomics of atherosclerosis.

Merched AJ, Chan L.

Curr Atheroscler Rep. 2013 Jun;15(6):328. doi: 10.1007/s11883-013-0328-6. Review.

14.

Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease.

Camarca A, Anderson RP, Mamone G, Fierro O, Facchiano A, Costantini S, Zanzi D, Sidney J, Auricchio S, Sette A, Troncone R, Gianfrani C.

J Immunol. 2009 Apr 1;182(7):4158-66. doi: 10.4049/jimmunol.0803181.

15.

Anti-gliadin antibody specificity for gluten-derived peptides toxic to coeliac patients.

Devery JM, La Brooy JT, Krillis S, Davidson G, Skerritt JH.

Clin Exp Immunol. 1989 Jun;76(3):384-90.

16.

Usefulness of recombinant γ-gliadin 1 for identifying patients with celiac disease and monitoring adherence to a gluten-free diet.

Srinivasan B, Focke-Tejkl M, Weber M, Pahr S, Baar A, Atreya R, Neurath MF, Vogelsang H, Huber WD, Valenta R.

J Allergy Clin Immunol. 2015 Dec;136(6):1607-18.e1-3. doi: 10.1016/j.jaci.2015.04.040. Epub 2015 Jun 13.

17.

Immunologic evidence of no harmful effect of oats in celiac disease.

Picarelli A, Di Tola M, Sabbatella L, Gabrielli F, Di Cello T, Anania MC, Mastracchio A, Silano M, De Vincenzi M.

Am J Clin Nutr. 2001 Jul;74(1):137-40.

18.

Comprehensive, quantitative mapping of T cell epitopes in gluten in celiac disease.

Tye-Din JA, Stewart JA, Dromey JA, Beissbarth T, van Heel DA, Tatham A, Henderson K, Mannering SI, Gianfrani C, Jewell DP, Hill AV, McCluskey J, Rossjohn J, Anderson RP.

Sci Transl Med. 2010 Jul 21;2(41):41ra51. doi: 10.1126/scitranslmed.3001012.

19.

Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?

Lindfors K, Mäki M, Kaukinen K.

Autoimmun Rev. 2010 Sep;9(11):744-9. doi: 10.1016/j.autrev.2010.06.003. Epub 2010 Jun 12. Review.

PMID:
20547248
20.

Mass spectrometry analysis of gliadins in celiac disease.

Ferranti P, Mamone G, Picariello G, Addeo F.

J Mass Spectrom. 2007 Dec;42(12):1531-48. Review.

PMID:
18085572

Supplemental Content

Support Center